<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02887417</url>
  </required_header>
  <id_info>
    <org_study_id>Glioma-HGW</org_study_id>
    <nct_id>NCT02887417</nct_id>
  </id_info>
  <brief_title>Glioblastoma Platelet Activation Study</brief_title>
  <acronym>GPAS</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>University Medicine Greifswald</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Medicine Greifswald</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Glioblastoma face an increased risk of venous or arterial thromboembolism. Furthermore, the
      most frequent immune cells in glioblastoma are tumor associated macrophages, which find
      theirself in an anti-inflammatory (M2) phenotype.

      Increased conjugates between circulating platelets and monocytes reflect an pro-inflammatory
      status.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Glioblastoma face an increased risk of venous or arterial thromboembolism. Furthermore, the
      most frequent immune cells in glioblastoma are tumor associated macrophages, which find
      theirself in an anti-inflammatory (M2) phenotype.

      Increased conjugates between circulating platelets and monocytes reflect an pro-inflammatory
      status.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">October 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mean P-selectine expression in all platelets</measure>
    <time_frame>01/ 2016 - 10/ 2016</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean CD63 expression in all platelets</measure>
    <time_frame>01/ 2016 - 10/ 2016</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean CD40 Expression in all platelets</measure>
    <time_frame>01/ 2016 - 10/ 2016</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean platelet-monocyte-conjugate formation in the monocyte population</measure>
    <time_frame>01/ 2016 - 10/ 2016</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">21</enrollment>
  <condition>Glioblastoma</condition>
  <condition>Circulating Platelet-monocyte Conjugates</condition>
  <arm_group>
    <arm_group_label>patients</arm_group_label>
    <description>glioblastoma patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>controls</arm_group_label>
    <description>healthy controls</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        consecutive patients with suspicious for glioblastoma
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  MR-morphological suspicion for glioblastoma

          -  informed consent

        Exclusion Criteria:

          -  no informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Neurosurgery</name>
      <address>
        <city>Greifswald</city>
        <zip>17475</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 18, 2016</study_first_submitted>
  <study_first_submitted_qc>August 29, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 2, 2016</study_first_posted>
  <last_update_submitted>July 31, 2017</last_update_submitted>
  <last_update_submitted_qc>July 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Medicine Greifswald</investigator_affiliation>
    <investigator_full_name>Sascha Marx</investigator_full_name>
    <investigator_title>Dr. med.</investigator_title>
  </responsible_party>
  <keyword>platelet activation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glioblastoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

